Skip to main content
. 2015 Nov 26;16(7):497–503. doi: 10.5152/AnatolJCardiol.2015.6240

Table 2.

Characteristics of patients

Variable TASC-A n=162 TASC-B n=97 TASC-C n=53 TASC-D n=31 P*
Age, year 64.60±10.09 65.14±9.69 63.87±9.37 67.87±7.50 0.292
Male, n % 126 (77.8) 93 (95.6) 53 (100) 31 (100) <0.001
CAD, n % 77 (47.5) 56 (57.7) 35 (66.0) 24 (77.4) 0.005
Smoking, n % 73 (45.1) 47 (48.5) 27 (50.9) 18 (58.1) 0.571
HT, n % 77 (47.5) 52 (53.6) 29 (54.7) 16 (51.6) 0.722
HL, n % 49 (30.2) 31 (32.0) 23 (43.4) 11 (35.5) 0.353
LDL, mg/dL 134.72±34.35 140.20±33.19 162.55±52.14 139.87±53.61 <0.001
HDL, mg/dL 38.79±6.89 37.62±6.11 35.38±5.31 36.77±9.51 0.012
DM, n % 56 (34.6) 24 (29.3) 18 (34.0) 9 (29.0) 0.928
CRF, n % 41 (25.3) 17 (17.5) 9 (17) 3 (9.7) 0.140
LVEF, % 58.90±10.43 57.16±9.57 58.55±10.37 56.23±8.97 0.386
Glucose, mg/dL 105 (33.25) 105 (28.5) 105 (27.5) 103 (20) 0.661
Creatinine, mg/dL 1.00 (0.33) 0.96 (0.36) 1.00 (0.38) 1.04 (0.18) 0.410
GFR, ml/min/1.73 m2 80.55±28.10 85.74±31.33 82.65±35.12 77.43±16.24 0.437
Neutrophil 4.19±1.22 5.21±1.30 5.48±1.36 5.70±1.21 <0.001
Lymphocyte 1.66±0.53 1.61±0.50 1.49±0.60 1.36±0.48 0.012
N/L ratio 2.45 (0.89) 3.28 (1.50) 3.57 (2.96) 4.23 (2.09) <0.001
*

Chi-square, analysis of variance and Kruskal-Wallis test

CAD - coronary artery disease; CRF - chronic renal failure (Glomerular filtration rate<60 ml/min/1.73 m2); DM - diabetes mellitus; GFR - estimated glomerular filtration rate; HDL - high density lipoprotein cholesterol; HL - hyperlipdemia; HT - hypertension; LDL - low density lipoprotein cholesterol; LVEF - left ventricle ejection fraction; N/L ratio - neutrophil/lymphocyte ratio; PAD - peripheral artery disease; TASC - Trans Atlantic Inter-Society Consensus II classification

Post hoc analysis:

LDL-TASC-A vs. TASC-B p=0.699, TASC-A vs. TASC-C p<0.001, TASC-A vs. TASC-D p=.909, TASC-B vs. TASC-C p=0.005, TASC-B vs. TASC-D p=1.000, TASC-C vs. TASC-D p= 0.054

HDL-TASC-A vs. TASC-B p=0.528, TASC-A vs. TASC-C p=0.008, TASC-A vs. TASC-D p=0.423, TASC-B vs. TASC-C p=0.211, TASC-B vs. TASC-D p=0.930, TASC-C vs. TASC-D p=0.796

Neutrophil-TASC-A vs. TASC-B p<0.001, TASC-A vs. TASC-C p<0.001, TASC-A vs. TASC-D p<0.001, TASC-B vs. TASC-C p=0.582, TASC-B vs. TASC-D p=0.238, TASC-C vs. TASC-D p=0.874

Lymphocyte-TASC-A vs. TASC-B p=0.827, TASC-A vs. TASC-C p=0.19, TASC-A vs. TASC-D p=0.018, TASC-B vs. TASC-C p=0.570, TASC-B vs. TASC-D p=0.106, TASC-C vs. TASC-D p= 0.690

N/L ratio- TASC-A vs. TASC-B p<0.001, TASC-A vs. TASC-C p<0.001, TASC-A vs. TASC-D p<0.001, TASC-B vs. TASC-C p=0.044, TASC-B vs. TASC-D p=0.001, TASC-C vs. TASC-D p= 0.252